, a medication containing the main chemical anastrozole, represents a significant development in the treatment of breast cancer, particularly in postmenopausal women. Altraz, an aromatase inhibitor, acts by inhibiting the enzyme aromatase, hence lowering estrogen production in the body. This pathway is critical in hormone receptor-positive breast cancer, as estrogen promotes tumor growth. Altraz is an important part of breast cancer management, acting as both an added benefit after surgery or radiation and a first-line treatment for metastatic disease. By suppressing estrogen activity, it helps to starve cancer cells, limiting their proliferation and lowering the likelihood of recurrence. Altraz is a cornerstone in the complete approach to breast cancer treatment, providing patients with better outcomes and a higher quality of life as they fight this disease.
Here you have more information: